BRAIN Act of 2021

2021-09-30

Introduced in House

Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021

This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence.

The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system.

The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.

]]>

text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.